Melody McLaren, a friend of mine, lives in London. Her husband has Parkinson’s Disease and receives treatment through the National Health Service. His treatment has included “ deep brain stimulation” — implantation of an electrical device that stimulates subcortical brain areas. It is a standard treatment for Parkinson’s. It cost the National Health Service about £35,000.
She was surprised to discover that in the United States, the same procedure involved implantation of two batteries, one for each side of the brain. The device implanted in England has only one battery. It worked fine. My friend wondered why two batteries were used in the United States. She asked her husband’s neurologist, a French woman practicing in London. “Because it costs more,” she said. There was no other reason.
At the San Mateo Maker’s Faire a few weeks ago, I heard a talk by a doctor named Amy Baxter, who had developed a device for pediatricians that makes shots hurt less. (She had a child and noticed the problem.) She went to considerable trouble to develop a product that could be used by working doctors and presented the product several times to potential buyers. Again and again she was told It has to be disposable. Meaning one use per package. Nothing else will fit the supply chain. She did not say why she was told this, but the obvious reason was that disposable products are more profitable.
Steven Brill’s cover story in Time two months ago was about one way American health care takes advantage of sick people with little choice — hospitals, including nonprofits, charge patients for products and services far more than what they cost the hospital. This is another way.